BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND RARA, RAR, 5914, ENSG00000131759, NR1B1
145 results:

  • 1. Development of Bexarotene Analogs for Treating Cutaneous T-Cell lymphomas.
    Warda A; Staniszewski LJP; Sabir Z; Livingston S; Sausedo M; Reshi S; Ron E; Applegate MT; Haddad D; Khamisi M; Marshall PA; Wagner CE; Jurutka PW
    Cells; 2023 Nov; 12(21):. PubMed ID: 37947652
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Use of tamibarotene, a potent and selective rarα agonist, in combination with azacitidine in patients with relapsed and refractory AML with
    Stein EM; de Botton S; Cluzeau T; Pigneux A; Liesveld JL; Cook RJ; Rousselot P; Rizzieri DA; Braun T; Roboz GJ; Lebon D; Heiblig M; Baker K; Volkert A; Paul S; Rajagopal N; Roth DA; Kelly M; Peterlin P
    Leuk Lymphoma; 2023 Dec; 64(12):1992-2001. PubMed ID: 37571998
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene.
    Jurutka PW; di Martino O; Reshi S; Mallick S; Sausedo MA; Moen GA; Lee IJ; Ivan DJ; Krall TD; Peoples SJ; Perez A; Tromba L; Le A; Khadka I; Petros R; Savage BM; Salama E; Salama J; Ziller JW; Noh Y; Lee MY; Liu W; Welch JS; Marshall PA; Wagner CE
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555852
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cinobufagin induces acute promyelocytic leukaemia cell apoptosis and PML-rara degradation in a caspase-dependent manner by inhibiting the β-catenin signalling pathway.
    Bian Y; Xue M; Guo X; Jiang W; Zhao Y; Zhang Z; Wang X; Hu Y; Zhang Q; Dun W; Zhang L
    Pharm Biol; 2022 Dec; 60(1):1801-1811. PubMed ID: 36121296
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy.
    Ramos Perez JM; Patel KP; Loghavi S; Garcia-Manero G; Borthakur G; Jabbour E; Wierda W; Pierce S; Brandt M; Kornblau S; Kadia T; Daver N; DiNardo CD; Jain N; Yilmaz M; Short N; Verstovsek S; Ferrajoli A; Andreeff M; Konopleva M; Rivera D; McCue D; Kantarjian HM; Ravandi F
    Leuk Lymphoma; 2022 Mar; 63(3):672-675. PubMed ID: 34668451
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathological Evaluation of Acute Leukemias in a Tertiary Care Hospital: A Cross-Sectional Study.
    Patel GN; Gudur R; Gudur A; Oswal RM; Kanethkar S
    Turk Patoloji Derg; 2021; 37(2):145-153. PubMed ID: 33973643
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Preleukemic fusion genes typical for acute myeloid leukemia.
    Klimová D; Styk J; Svoboda M; Humplíková S; Repiská V
    Vnitr Lek; 2021; 67(E-5):9-12. PubMed ID: 35459386
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Therapy-related acute promyelocytic leukemia with complex karyotype accompanied by cryptic PML/rara on chromosome 15 by metaphase FISH].
    Kashima E; Sugimoto Y; Nato Y; Ino K; Tawara I; Masuya M; Katayama N
    Rinsho Ketsueki; 2020; 61(11):1577-1583. PubMed ID: 33298649
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparison of gene regulatory networks to identify pathogenic genes for lymphoma.
    Yu X; Weng T; Gu C; Yang H
    J Bioinform Comput Biol; 2020 Oct; 18(5):2050029. PubMed ID: 33131362
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Gene of the month:
    Nathany S; Tripathi R; Mehta A
    J Clin Pathol; 2021 Jan; 74(1):1-4. PubMed ID: 32907914
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Fertility in female cancer survivors: a systematic review and meta-analysis.
    Busnelli A; Vitagliano A; Mensi L; Acerboni S; Bulfoni A; Filippi F; Somigliana E
    Reprod Biomed Online; 2020 Jul; 41(1):96-112. PubMed ID: 32456969
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Monotherapy and combination therapy with acitretin for mycosis fungoides: results of a retrospective, multicentre study.
    Nikolaou V; Patsatsi A; Sidiropoulou P; Chlouverakis G; Kavvalou E; Koletsa T; Economidi A; Georgiou E; Papadavid E; Rigopoulos D; Stratigos AJ; Kruger-Krasagakis SE
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2534-2540. PubMed ID: 32364303
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Morphologic and genetic heterogeneity in breast fibroepithelial lesions-a comprehensive mapping study.
    Tan BY; Md Nasir ND; Chang HY; Ng CCY; Guan P; Nagarajan S; Rajasegaran V; Lee JY; Lim JQ; Thike AA; Teh BT; Tan PH
    Mod Pathol; 2020 Sep; 33(9):1732-1745. PubMed ID: 32322022
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Neoantigens in Hematologic Malignancies.
    Biernacki MA; Bleakley M
    Front Immunol; 2020; 11():121. PubMed ID: 32117272
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic Significance of bcr-1 and bcr-3 Isoforms of PML-rara and FLT3-ITD in Patients With Acute Promyelocytic Leukemia.
    Rasekh EO; Elsayed GM; Madney Y; El Gammal MM
    Clin Lymphoma Myeloma Leuk; 2020 Mar; 20(3):156-167. PubMed ID: 32033928
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genomic characterisation of breast fibroepithelial lesions in an international cohort.
    Md Nasir ND; Ng CCY; Rajasegaran V; Wong SF; Liu W; Ng GXP; Lee JY; Guan P; Lim JQ; Thike AA; Koh VCY; Loke BN; Chang KTE; Gudi MA; Lian DWQ; Madhukumar P; Tan BKT; Tan VKM; Wong CY; Yong WS; Ho GH; Ong KW; ; Tan P; Teh BT; Tan PH
    J Pathol; 2019 Dec; 249(4):447-460. PubMed ID: 31411343
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN.
    Wagner CE; Jurutka PW
    Methods Mol Biol; 2019; 2019():109-121. PubMed ID: 31359392
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Methods to Assess Activity and Potency of Rexinoids Using Rapid Luciferase-Based Assays: A Case Study with NEt-TMN.
    Jurutka PW; Wagner CE
    Methods Mol Biol; 2019; 2019():95-108. PubMed ID: 31359391
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Incidence and Immunophenotypic and Genetic Features of JL1 Expressing Cells and the Therapeutic Potential of an Anti-JL1 Antibody in
    Park SH; You E; Park CJ; Jang S; Cho YU; Yoon CH; Koh KN; Im HJ; Seo JJ
    Ann Lab Med; 2019 Jul; 39(4):358-366. PubMed ID: 30809981
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
    Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
    Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.